![](https://endpts.com/wp-content/uploads/2023/04/Christopher-Barden-Treventis-CEO.jpg)
Christopher Barden, Treventis CEO
Takeda joins forces with small private biotech for preclinical Alzheimer's research
Takeda is wading deeper into Alzheimer’s disease research with a new preclinical collaboration announced Tuesday.
The company will work with Treventis, a little-known private biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.